MYC and teratoma: However, there are limitations, such as the difficulty with the combined administration of these transcription factors due to their size, which exceeds the capacity of lentiviruses; the formation of teratomas with the use of c-Myc; and the possibility of replicating these results in humans (Figure 3) [49].